X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs TEVA PHARMA (Israel) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   TEVA PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
TEVA PHARMA
Dec-13
ALEMBIC LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs722,880-   
Low Rs342,502-   
Sales per share (Unadj.) Rs4.71,652.7-  
Earnings per share (Unadj.) Rs6.1103.2-  
Cash flow per share (Unadj.) Rs6.2236.8-  
Dividends per share (Unadj.) Rs0.2090.38-  
Dividend yield (eoy) %0.43.4 11.2%  
Book value per share (Unadj.) Rs40.71,835.8-  
Shares outstanding (eoy) m267.03848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.31.6 691.9%   
Avg P/E ratio x8.726.1 33.3%  
P/CF ratio (eoy) x8.511.4 74.6%  
Price / Book Value ratio x1.31.5 88.9%  
Dividend payout %3.387.5 3.7%   
Avg Mkt Cap Rs m14,1392,281,637 0.6%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2070-   
Avg. sales/employee Rs ThNM31,181.7-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,947.9-  
INCOME DATA
Net Sales Rs m1,2551,401,463 0.1%  
Other income Rs m3700-   
Total revenues Rs m1,6251,401,463 0.1%   
Gross profit Rs m111383,791 0.0%  
Depreciation Rs m38113,282 0.0%   
Interest Rs m227,527 0.0%   
Profit before tax Rs m442242,983 0.2%   
Minority Interest Rs m01,104 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-159,505 0.0%   
Tax Rs m24-2,967 -0.8%   
Profit after tax Rs m1,63087,548 1.9%  
Gross profit margin %8.927.4 32.3%  
Effective tax rate %5.4-1.2 -444.0%   
Net profit margin %129.86.2 2,078.6%  
BALANCE SHEET DATA
Current assets Rs m1,867946,543 0.2%   
Current liabilities Rs m591825,465 0.1%   
Net working cap to sales %101.68.6 1,176.6%  
Current ratio x3.21.1 275.4%  
Inventory Days Days9491 103.8%  
Debtors Days Days7496 76.7%  
Net fixed assets Rs m1,791457,749 0.4%   
Share capital Rs m5343,450 15.5%   
"Free" reserves Rs m10,3240-   
Net worth Rs m10,8581,556,759 0.7%   
Long term debt Rs m41716,599 0.0%   
Total assets Rs m11,5913,202,792 0.4%  
Interest coverage x260.99.8 2,654.7%   
Debt to equity ratio x00.5 0.8%  
Sales to assets ratio x0.10.4 24.7%   
Return on assets %14.13.6 391.8%  
Return on equity %15.05.6 266.9%  
Return on capital %15.24.9 308.0%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Net fx Rs m-2440-   
CASH FLOW
From Operations Rs m236223,321 0.1%  
From Investments Rs m-224-79,132 0.3%  
From Financial Activity Rs m-27-267,888 0.0%  
Net Cashflow Rs m-15-123,699 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.99 Rs / USD

Compare ALEMBIC LTD With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ALEMBIC LTD With: DIVIS LABORATORIES  ALKEM LABORATORIES  TTK HEALTHCARE  CADILA HEALTHCARE  GSK PHARMA  



Today's Market

Sensex Ends Marginally Higher; Realty and Energy Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector.

Related Views On News

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

The Jet Airways Crisis in 6 Charts(Sector Info)

Mar 5, 2019

What happened to Jet Airways, once among top 3 airlines in India? Is it another Kingfisher in the making? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Mar 18, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS